Anebulo Pharmaceuticals I... (ANEB)
1.63
-0.01 (-0.61%)
At close: Jan 15, 2025, 12:59 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 |
| Net Income | -8.20M | -11.73M | -6.83M | -30.25M | -174.64K |
| Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 758.88K | 884.72K | 480.66K | 199.95K | n/a |
| Other Working Capital | -421.14K | -153.72K | 637.00K | -1.56M | 22.58K |
| Other Non-Cash Items | 151.23K | 731.01K | 209.88K | 26.63M | 1.29K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -799.26K | 1.16M | 907.78K | -1.45M | 22.58K |
| Operating Cash Flow | -8.09M | -9.68M | -5.44M | -4.87M | -150.77K |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | -201.29K | 200.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -62.35K | -264.68K | n/a | -821.63K | n/a |
| Financial Cash Flow | -62.35K | 6.38M | n/a | 21.83M | 3.18M |
| Net Cash Flow | -8.15M | -3.30M | -5.44M | 16.96M | 3.02M |
| Free Cash Flow | -8.09M | -9.68M | -5.44M | -4.87M | -150.77K |